305 related articles for article (PubMed ID: 18039686)
21. A G-to-T transversion at the splice acceptor site of dystrophin exon 14 shows multiple splicing outcomes that are not exemplified by transition mutations.
Ota M; Takeshima Y; Nishida A; Awano H; Lee T; Yagi M; Matsuo M
Genet Test Mol Biomarkers; 2012 Jan; 16(1):3-8. PubMed ID: 21854195
[TBL] [Abstract][Full Text] [Related]
22. Exon inclusion is dependent on predictable exonic splicing enhancers.
Zhang XH; Kangsamaksin T; Chao MS; Banerjee JK; Chasin LA
Mol Cell Biol; 2005 Aug; 25(16):7323-32. PubMed ID: 16055740
[TBL] [Abstract][Full Text] [Related]
23. Unclassified variants identified in BRCA1 exon 11: Consequences on splicing.
Anczuków O; Buisson M; Salles MJ; Triboulet S; Longy M; Lidereau R; Sinilnikova OM; Mazoyer S
Genes Chromosomes Cancer; 2008 May; 47(5):418-26. PubMed ID: 18273839
[TBL] [Abstract][Full Text] [Related]
24. A unique intronic splicing enhancer controls the inclusion of the agrin Y exon.
Wei N; Lin CQ; Modafferi EF; Gomes WA; Black DL
RNA; 1997 Nov; 3(11):1275-88. PubMed ID: 9409619
[TBL] [Abstract][Full Text] [Related]
25. Predictive identification of exonic splicing enhancers in human genes.
Fairbrother WG; Yeh RF; Sharp PA; Burge CB
Science; 2002 Aug; 297(5583):1007-13. PubMed ID: 12114529
[TBL] [Abstract][Full Text] [Related]
26. A novel mutation (c.951C>T) in an exonic splicing enhancer results in exon 10 skipping in the human mitochondrial acetoacetyl-CoA thiolase gene.
Fukao T; Horikawa R; Naiki Y; Tanaka T; Takayanagi M; Yamaguchi S; Kondo N
Mol Genet Metab; 2010 Aug; 100(4):339-44. PubMed ID: 20488739
[TBL] [Abstract][Full Text] [Related]
27. Novel cryptic exons identified in introns 2 and 3 of the human dystrophin gene with duplication of exons 8-11.
Ishibashi K; Takeshima Y; Yagi M; Nishiyama A; Matsuo M
Kobe J Med Sci; 2006; 52(3-4):61-75. PubMed ID: 16849873
[TBL] [Abstract][Full Text] [Related]
28. Multiple sequence variants of BRCA2 exon 7 alter splicing regulation.
Gaildrat P; Krieger S; Di Giacomo D; Abdat J; Révillion F; Caputo S; Vaur D; Jamard E; Bohers E; Ledemeney D; Peyrat JP; Houdayer C; Rouleau E; Lidereau R; Frébourg T; Hardouin A; Tosi M; Martins A
J Med Genet; 2012 Oct; 49(10):609-17. PubMed ID: 22962691
[TBL] [Abstract][Full Text] [Related]
29. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
30. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
[TBL] [Abstract][Full Text] [Related]
31. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
[TBL] [Abstract][Full Text] [Related]
32. A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution.
Dwi Pramono ZA; Takeshima Y; Surono A; Ishida T; Matsuo M
Biochem Biophys Res Commun; 2000 Jan; 267(1):321-8. PubMed ID: 10623618
[TBL] [Abstract][Full Text] [Related]
33. Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse.
Buvoli M; Buvoli A; Leinwand LA
PLoS One; 2007 May; 2(5):e427. PubMed ID: 17487273
[TBL] [Abstract][Full Text] [Related]
34. Complex expression pattern of RPGR reveals a role for purine-rich exonic splicing enhancers.
Hong DH; Li T
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3373-82. PubMed ID: 12407146
[TBL] [Abstract][Full Text] [Related]
35. Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA.
Hayakawa M; Sakashita E; Ueno E; Tominaga S; Hamamoto T; Kagawa Y; Endo H
J Biol Chem; 2002 Mar; 277(9):6974-84. PubMed ID: 11744705
[TBL] [Abstract][Full Text] [Related]
36. SNPSplicer: systematic analysis of SNP-dependent splicing in genotyped cDNAs.
ElSharawy A; Manaster C; Teuber M; Rosenstiel P; Kwiatkowski R; Huse K; Platzer M; Becker A; Nürnberg P; Schreiber S; Hampe J
Hum Mutat; 2006 Nov; 27(11):1129-34. PubMed ID: 16937379
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing of fibronectin mRNAs in chondrosarcoma cells: role of far upstream intron sequences.
Flanagan M; Liang H; Norton PA
J Cell Biochem; 2003 Nov; 90(4):709-18. PubMed ID: 14587027
[TBL] [Abstract][Full Text] [Related]
38. A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition.
Fang LJ; Simard MJ; Vidaud D; Assouline B; Lemieux B; Vidaud M; Chabot B; Thirion JP
J Mol Biol; 2001 Apr; 307(5):1261-70. PubMed ID: 11292340
[TBL] [Abstract][Full Text] [Related]
39. Characterization of two novel GBA mutations causing Gaucher disease that lead to aberrant RNA species by using functional splicing assays.
Dominissini S; Buratti E; Bembi B; Baralle M; Pittis MG
Hum Mutat; 2006 Jan; 27(1):119. PubMed ID: 16329099
[TBL] [Abstract][Full Text] [Related]
40. A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5.
Suminaga R; Takeshima Y; Adachi K; Yagi M; Nakamura H; Matsuo M
J Hum Genet; 2002; 47(4):196-201. PubMed ID: 12166656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
